|
审核状态: Project audit state: |
通过审核 Successful |
|
注册号: Registration number: |
ChiCTR2500106848 |
|
最近更新日期: Date of Last Refreshed on: |
2025-07-30 22:13:55 |
|
注册时间: Date of Registration: |
2025-07-30 00:00:00 |
|
注册号状态: |
预注册 |
|
Registration Status: |
Prospective registration |
|
注册题目: |
智能化患者自控镇痛效果中国疼痛评估量表的研制和验证 |
|
Public title: |
Development and validation of the Chinese pain assessment scale for artificial intelligence patient-controlled analgesia |
|
注册题目简写: |
|
|
English Acronym: |
|
|
研究课题的正式科学名称: |
智能化患者自控镇痛效果中国疼痛评估量表的研制和验证 |
|
Scientific title: |
Development and validation of the Chinese pain assessment scale for artificial intelligence patient-controlled analgesia |
|
研究课题代号(代码): Study subject ID: |
|
|
在二级注册机构或其它机构的注册号: The registration number of the Partner Registry or other register: |
|
申请注册联系人: |
王琰 |
研究负责人: |
储勤军 |
|
Applicant: |
Wangyan |
Study leader: |
Chu qinjun |
|
申请注册联系人电话: Applicant telephone: |
+86 135 0371 4779 |
研究负责人电话:
Study leader's |
+86 136 4371 1142 |
|
申请注册联系人传真 : Applicant Fax: |
研究负责人传真: Study leader's fax: |
||
|
申请注册联系人电子邮件: Applicant E-mail: |
wangy0377@126.com |
研究负责人电子邮件: Study leader's E-mail: |
jimmynetchu@163.com |
|
申请单位网址(自愿提供): Applicant website(voluntary supply): |
研究负责人网址(自愿提供): Study leader's website(voluntary supply): |
||
|
申请注册联系人通讯地址: |
郑州市中原区桐柏北路16号 |
研究负责人通讯地址: |
郑州市中原区桐柏北路16号 |
|
Applicant address: |
16 Tongbai North Road, Zhongyuan District, Zhengzhou City |
Study leader's address: |
16 Tongbai North Road, Zhongyuan District, Zhengzhou City 1 |
|
申请注册联系人邮政编码: Applicant postcode: |
研究负责人邮政编码: Study leader's postcode: |
||
|
申请人所在单位: |
郑州大学附属郑州中心医院 |
||
|
Applicant's institution: |
Zhengzhou Central Hospital Affiliated to Zhengzhou University |
||
|
研究负责人所在单位: |
郑州大学附属郑州中心医院 |
||
|
Affiliation of the Leader: |
Zhengzhou Central Hospital Affiliated to Zhengzhou University |
||
|
是否获伦理委员会批准: |
是 |
||
|
Approved by ethic committee: |
Yes |
||
|
伦理委员会批件文号: Approved No. of ethic committee: |
ZXYY2025067 |
伦理委员会批件附件: Approved file of Ethical Committee: |
查看附件View |
|
批准本研究的伦理委员会名称: |
郑州市中心医院医学伦理委员会 |
||
|
Name of the ethic committee: |
Medical Ethics Committee of Zhengzhou Central Hospital |
||
|
伦理委员会批准日期: Date of approved by ethic committee: |
2025-05-20 00:00:00 | ||
|
伦理委员会联系人: |
白丹 |
||
|
Contact Name of the ethic committee: |
Dan Bai |
||
|
伦理委员会联系地址: |
郑州市中原区桐柏北路16号 |
||
|
Contact Address of the ethic committee: |
16 Tongbai North Road, Zhongyuan District, Zhengzhou City |
||
|
伦理委员会联系人电话: Contact phone of the ethic committee: |
+86 371 6711 0929 |
伦理委员会联系人邮箱: Contact email of the ethic committee: |
|
|
研究实施负责(组长)单位: |
郑州大学附属郑州中心医院 |
||||||||||||||||||||||
|
Primary sponsor: |
Zhengzhou Central Hospital Affiliated To Zhengzhou University |
||||||||||||||||||||||
|
研究实施负责(组长)单位地址: |
郑州市中原区桐柏北路16号 |
||||||||||||||||||||||
|
Primary sponsor's address: |
16 Tongbai North Road, Zhongyuan District, Zhengzhou City |
||||||||||||||||||||||
|
试验主办单位(项目批准或申办者): Secondary sponsor: |
|
||||||||||||||||||||||
|
经费或物资来源: |
医院科研经费 |
||||||||||||||||||||||
|
Source(s) of funding: |
Hospital research funding |
||||||||||||||||||||||
|
研究疾病: |
急性疼痛 |
||||||||||||||||||||||
|
Target disease: |
Acute pain |
||||||||||||||||||||||
|
研究疾病代码: |
|
||||||||||||||||||||||
|
Target disease code: |
|
||||||||||||||||||||||
|
研究类型: |
观察性研究 |
||||||||||||||||||||||
|
Study type: |
Observational study |
||||||||||||||||||||||
|
研究所处阶段: |
其它 | ||||||||||||||||||||||
|
Study phase: |
N/A |
||||||||||||||||||||||
|
研究设计: |
横断面 |
||||||||||||||||||||||
|
Study design: |
Cross-sectional |
||||||||||||||||||||||
|
研究目的: |
通过对智能化患者自控镇痛效果中国疼痛量表初始版进行效信度进行评价,根据分析结果对量表进一步修订完善,建立适用于我国国情的智能化患者自控镇痛效果中国疼痛评估量表。 |
||||||||||||||||||||||
|
Objectives of Study: |
The validity and reliability of the initial version of the Chinese Pain Assessment Scale for artificial intelligence Patient-Controlled analgesia was evaluated, and the scale was further revised and improved according to the analysis results, so as to establish the Chinese pain assessment scale for artificial intelligence Patient-controlled analgesia suitable for China's national conditions. To improve the accuracy of analgesic effect evaluation during the use of PCA pump, reduce adverse reactions and the effect of analgesic pump failure on analgesia, improve patient satisfaction and prognosis. |
||||||||||||||||||||||
|
药物成份或治疗方案详述: |
|
||||||||||||||||||||||
|
Description for medicine or protocol of treatment in detail: |
|
||||||||||||||||||||||
|
纳入标准: |
年龄大于18岁成人手术患者;ASA分级1-5 级;择期住院外科手术患者包括普外科、泌尿科、骨科、妇科、胸外科;患者术后使用静脉自控镇痛智能医嘱泵(型号REHN-11);患者能理解量表的内容且愿意参加量表验证。 |
||||||||||||||||||||||
|
Inclusion criteria |
Aged from 18 to 65 years; ASA grade 1-3; Patients undergoing elective surgery included general surgery, urology, orthopedics, gynecology, and thoracic surgery. Patients were treated with patient-controlled intravenous analgesia intelligent doctor's advice pump (model REHN-11) after operation. Patients understood the content of the scale and were willing to participate in the validation of the scale. |
||||||||||||||||||||||
|
排除标准: |
有脑血管、癫痫及其他中枢神经系统疾病的患者;沟通有障碍的患者;术后计划转入ICU的患者。 |
||||||||||||||||||||||
|
Exclusion criteria: |
Patients with cerebrovascular, epilepsy and other central nervous system diseases; Patients with communication difficulties; Patients scheduled to be transferred to the ICU after surgery. |
||||||||||||||||||||||
|
研究实施时间: Study execute time: |
从 From 2025-06-01 00:00:00至 To 2025-12-31 00:00:00 |
征募观察对象时间: Recruiting time: |
从 From 2025-08-01 00:00:00 至 To 2025-09-30 00:00:00 |
|
干预措施: Interventions: |
|
|
研究实施地点: Countries of recruitment and research settings: |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
测量指标: Outcomes: |
|
|
采集人体标本:
Collecting sample(s)
|
|
|
征募研究对象情况: Recruiting status: |
尚未开始 Not yet recruiting |
年龄范围: Participant age: |
|
||||||
|
性别: |
男女均可 |
Gender: |
Both |
||||||
|
随机方法(请说明由何人用什么方法产生随机序列): |
无 |
||||||||
|
Randomization Procedure (please state who generates the random number sequence and by what method): |
None |
||||||||
|
是否公开试验完成后的统计结果: Calculated Results after the Study Completed public access: |
公开/Public |
|
盲法: |
|
|
Blinding: |
|
|
试验完成后的统计结果(上传文件): |
|
|
Calculated Results after
|
|
|
是否共享原始数据: IPD sharing |
是Yes |
|
共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址): |
研究完成后在郑州大学附属郑州中心医院麻醉科平台共享数据 |
|
The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url): |
After the completion of the study, the anesthesiology platform of Zhengzhou Central Hospital affiliated to Zhengzhou University was conducted. |
|
数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC: |
使用电子病例记录表采集数据。 |
|
Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture: |
Data were collected with the use of an electronic case-record form. |
|
数据与安全监察委员会: Data and Safety Monitoring Committee: |
暂未确定/Not yet |